FGFR1 and non-small cell lung carcinoma: In the current study we demonstrate that high level expression of ABCB1 is underlying acquired nintedanib resistance of the FGFR1-driven SCLC cell line DMS114 but not of the two NSCLC cell lines NCI-H1703 and NCI-H520.